Annexon
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annexon and other ETFs, options, and stocks.About ANNX
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy.
CEODouglas Love
CEODouglas Love
Employees100
Employees100
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees100
Employees100
ANNX Key Statistics
Market cap896.67M
Market cap896.67M
Price-Earnings ratio-4.40
Price-Earnings ratio-4.40
Dividend yield—
Dividend yield—
Average volume2.68M
Average volume2.68M
High today—
High today—
Low today—
Low today—
Open price$5.53
Open price$5.53
Volume0.00
Volume0.00
52 Week high$6.30
52 Week high$6.30
52 Week low$1.29
52 Week low$1.29
Stock Snapshot
The current Annexon(ANNX) stock price is $6.23, with a market capitalization of 896.67M. The stock trades at a price-to-earnings (P/E) ratio of -4.40.
Annexon(ANNX) stock opened on 2026-01-14 at $5.53. The price climbed to — and dipped to —.
The Annexon(ANNX)'s current trading volume is 0, compared to an average daily volume of 2.68M.
In the last year, Annexon(ANNX) shares hit a 52-week high of $6.30 and a 52-week low of $1.29.
In the last year, Annexon(ANNX) shares hit a 52-week high of $6.30 and a 52-week low of $1.29.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ANNX. This list is generated using Robinhood data, and it’s not a recommendation.